PortfoliosLab logoPortfoliosLab logo

Rydex Biotechnology Fund (RYOIX) Alternatives

Rydex Biotechnology Fund (RYOIX) belongs to the Health & Biotech Equities category. Below you'll find alternative mutual funds from the same category, ranked by key criteria, plus funds that investors commonly compare with RYOIX. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.

Cheapest Alternatives to RYOIX

RYOIX charges 1.36% annually. Among mutual funds in the Health & Biotech Equities category, these options have the lowest expense ratios among RYOIX alternatives.


Best Risk-Adjusted Alternatives to RYOIX

Among mutual funds in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.


Top Performing RYOIX Alternatives (YTD)

RYOIX alternatives from the Health & Biotech Equities category, sorted by year-to-date return.


Lowest Volatility Alternatives to RYOIX

RYOIX alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.


Lowest Drawdown Alternatives to RYOIX

RYOIX alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.


Other Mutual Funds from Rydex Funds

Most popular Rydex Funds mutual funds on PortfoliosLab, across asset classes.


Often Compared With RYOIX

What investors most often compare with RYOIX, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnInception
Vanguard S&P 500 ETFS&P 500
65
-4.42%
Sep 7, 2010RYOIX vs VOO

Compare RYOIX with Any Fund or Stock

Compare RYOIX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


Rydex Biotechnology Fund